LYMPHOCYTE SUBPOPULATIONS IN GASTRIC AND COLORECTAL CANCER PATIENTS AFTER IMMUNOTHERAPY WITH ACTIVATED LYMPHOCYTES

Phenotyping of peripheral blood lymphocytes and immune activation markers of activation (HLADR, CD38, CD69, CD314, CD25) was performed in thirteen patients with disseminated forms of stomach and rectal cancer before cell treatment, and following adoptive immunotherapy with activated lymphocytes. It...

Full description

Saved in:
Bibliographic Details
Main Authors: E. V. Abakushina, Yu. V. Marizina, G. S. Neprina, I. A. Pasova, B. A. Berdov
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2014-11-01
Series:Медицинская иммунология
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/732
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849241444602085376
author E. V. Abakushina
Yu. V. Marizina
G. S. Neprina
I. A. Pasova
B. A. Berdov
author_facet E. V. Abakushina
Yu. V. Marizina
G. S. Neprina
I. A. Pasova
B. A. Berdov
author_sort E. V. Abakushina
collection DOAJ
description Phenotyping of peripheral blood lymphocytes and immune activation markers of activation (HLADR, CD38, CD69, CD314, CD25) was performed in thirteen patients with disseminated forms of stomach and rectal cancer before cell treatment, and following adoptive immunotherapy with activated lymphocytes. It wasshown that the lymphocytes are well activated and are able to proliferate in vitro. It was revealed that the relative content of Tregs and NK cells is increased in these patients. After the courses of immunotherapy, initially low levels of B-cells (average 5%) remained in all the patients, whereas concentration of Тregs didn’t change. Increased expression of activation markers was revealed for all lymphocyte subsets (CD25, CD314, CD38, HLA-DR) and, especially, for T-lymphocytes (CD3+HLA-DR, CD3+CD38+). Significant decrease of T helpers, activated NK-cells (CD16+CD314+) and CD4+/CD8+ was noted in peripheral blood. A non-significant elevation in mature lymphocytes (CD45RO+) and reduced content of young lymphocytes (CD45RA+) were revealed. Adoptive immunotherapy is safe and well tolerated, being characterized by lack of side effects, and it may be recommended as a complement to conventional radio- and chemotherapy.
format Article
id doaj-art-ea42dd37277a49c1904ef89e931365df
institution Kabale University
issn 1563-0625
2313-741X
language Russian
publishDate 2014-11-01
publisher St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
record_format Article
series Медицинская иммунология
spelling doaj-art-ea42dd37277a49c1904ef89e931365df2025-08-20T04:00:09ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2014-11-0116544945610.15789/1563-0625-2014-5-449-456712LYMPHOCYTE SUBPOPULATIONS IN GASTRIC AND COLORECTAL CANCER PATIENTS AFTER IMMUNOTHERAPY WITH ACTIVATED LYMPHOCYTESE. V. Abakushina0Yu. V. Marizina1G. S. Neprina2I. A. Pasova3B. A. Berdov4Medical Radiological Research Center, Russian Ministry of Health Care, Obninsk, Russian FederationMedical Radiological Research Center, Russian Ministry of Health Care, Obninsk, Russian FederationMedical Radiological Research Center, Russian Ministry of Health Care, Obninsk, Russian FederationMedical Radiological Research Center, Russian Ministry of Health Care, Obninsk, Russian FederationMedical Radiological Research Center, Russian Ministry of Health Care, Obninsk, Russian FederationPhenotyping of peripheral blood lymphocytes and immune activation markers of activation (HLADR, CD38, CD69, CD314, CD25) was performed in thirteen patients with disseminated forms of stomach and rectal cancer before cell treatment, and following adoptive immunotherapy with activated lymphocytes. It wasshown that the lymphocytes are well activated and are able to proliferate in vitro. It was revealed that the relative content of Tregs and NK cells is increased in these patients. After the courses of immunotherapy, initially low levels of B-cells (average 5%) remained in all the patients, whereas concentration of Тregs didn’t change. Increased expression of activation markers was revealed for all lymphocyte subsets (CD25, CD314, CD38, HLA-DR) and, especially, for T-lymphocytes (CD3+HLA-DR, CD3+CD38+). Significant decrease of T helpers, activated NK-cells (CD16+CD314+) and CD4+/CD8+ was noted in peripheral blood. A non-significant elevation in mature lymphocytes (CD45RO+) and reduced content of young lymphocytes (CD45RA+) were revealed. Adoptive immunotherapy is safe and well tolerated, being characterized by lack of side effects, and it may be recommended as a complement to conventional radio- and chemotherapy.https://www.mimmun.ru/mimmun/article/view/732adoptive immunotherapyactivated lymphocytesgastric and colorectal cancerlymphocyte phenotypeperipheral blood
spellingShingle E. V. Abakushina
Yu. V. Marizina
G. S. Neprina
I. A. Pasova
B. A. Berdov
LYMPHOCYTE SUBPOPULATIONS IN GASTRIC AND COLORECTAL CANCER PATIENTS AFTER IMMUNOTHERAPY WITH ACTIVATED LYMPHOCYTES
Медицинская иммунология
adoptive immunotherapy
activated lymphocytes
gastric and colorectal cancer
lymphocyte phenotype
peripheral blood
title LYMPHOCYTE SUBPOPULATIONS IN GASTRIC AND COLORECTAL CANCER PATIENTS AFTER IMMUNOTHERAPY WITH ACTIVATED LYMPHOCYTES
title_full LYMPHOCYTE SUBPOPULATIONS IN GASTRIC AND COLORECTAL CANCER PATIENTS AFTER IMMUNOTHERAPY WITH ACTIVATED LYMPHOCYTES
title_fullStr LYMPHOCYTE SUBPOPULATIONS IN GASTRIC AND COLORECTAL CANCER PATIENTS AFTER IMMUNOTHERAPY WITH ACTIVATED LYMPHOCYTES
title_full_unstemmed LYMPHOCYTE SUBPOPULATIONS IN GASTRIC AND COLORECTAL CANCER PATIENTS AFTER IMMUNOTHERAPY WITH ACTIVATED LYMPHOCYTES
title_short LYMPHOCYTE SUBPOPULATIONS IN GASTRIC AND COLORECTAL CANCER PATIENTS AFTER IMMUNOTHERAPY WITH ACTIVATED LYMPHOCYTES
title_sort lymphocyte subpopulations in gastric and colorectal cancer patients after immunotherapy with activated lymphocytes
topic adoptive immunotherapy
activated lymphocytes
gastric and colorectal cancer
lymphocyte phenotype
peripheral blood
url https://www.mimmun.ru/mimmun/article/view/732
work_keys_str_mv AT evabakushina lymphocytesubpopulationsingastricandcolorectalcancerpatientsafterimmunotherapywithactivatedlymphocytes
AT yuvmarizina lymphocytesubpopulationsingastricandcolorectalcancerpatientsafterimmunotherapywithactivatedlymphocytes
AT gsneprina lymphocytesubpopulationsingastricandcolorectalcancerpatientsafterimmunotherapywithactivatedlymphocytes
AT iapasova lymphocytesubpopulationsingastricandcolorectalcancerpatientsafterimmunotherapywithactivatedlymphocytes
AT baberdov lymphocytesubpopulationsingastricandcolorectalcancerpatientsafterimmunotherapywithactivatedlymphocytes